title: MR/US Fusion Technology: What Makes It Tick?
abstract: MR/US fusion biopsy has emerged as a significant refinement of traditional prostate cancer diagnostic techniques. Utilizing not only quantitative imaging suspicion information from mpMRI but also the spatial accuracy and three-dimensional localization allows such strategies to specifically sample areas of concern with the gland. As such, diagnostic certainty is markedly improved. In this manuscript, we aim to highlight the multidisciplinary approach (amongst urologists, radiologists, pathologists, imaging technologists, nursing staff, and patients) which is required to launch and maintain a successful prostate imaging program.
authors.affiliation: Rush University Medical Center, 1725 W. Harrison Street, Suite 970 POB III, Chicago, IL, 60612, USA. srinivas_vourganti@rush.edu.
authors.forename: Srinivas
authors.initials: S
authors.lastname: Vourganti
authors.affiliation: State University of New York - Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA.
authors.forename: Norman
authors.initials: N
authors.lastname: Starkweather
authors.affiliation: State University of New York - Upstate Medical University, 750 E. Adams Street, Syracuse, NY, 13210, USA.
authors.forename: Andrij
authors.initials: A
authors.lastname: Wojtowycz
mesh_terms: D001706:Biopsy; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D064847:Multimodal Imaging; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D014463:Ultrasonography
keywords: Imaging; MR/US fusion biopsy; MRI; Prostate cancer